Andrew Sharabi MD
Associate Professor and Director of the Center for Precision Radiation Medicine
Join to View Full Profile
3855 Health Sciences DrLa Jolla, CA 92093
Dr. Sharabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2011 - 2015
Houston Methodist Hospital (Medical Center)Internship, Transitional Year, 2010 - 2011
Baylor College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation Start of enrollment: 2015 Jan 07
- Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease Start of enrollment: 2016 May 03
- SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2017 Oct 26
Publications & Presentations
PubMed
- Virus-mediated immunosuppression in head and neck cancer.Sayuri Miyauchi, Souvick Roy, Nathalie Boutros, Andrew B Sharabi
Oncogene. 2025-04-01 - 1 citationsRedefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk.Ryan T Morse, Tyler J Nelson, Hannah C Liu, Prangrawee Sangchan, Bhargava Chitti
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01 - Long-term treatment of metastatic adenoid cystic carcinoma with sequential brachytherapy and stereotactic body radiotherapy.Allison Y Zhong, Sangwoo S Kim, Austin Hopper, Greg White, Sayuri Miyauchi
Radiation Oncology Journal. 2024-09-01
Press Mentions
News & PublicationsMay 1st, 2024- Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022
- Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
